Thomas Gentinetta

918 total citations
15 papers, 426 citations indexed

About

Thomas Gentinetta is a scholar working on Cell Biology, Immunology and Molecular Biology. According to data from OpenAlex, Thomas Gentinetta has authored 15 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cell Biology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Thomas Gentinetta's work include Hemoglobin structure and function (5 papers), Food Allergy and Anaphylaxis Research (4 papers) and Mast cells and histamine (4 papers). Thomas Gentinetta is often cited by papers focused on Hemoglobin structure and function (5 papers), Food Allergy and Anaphylaxis Research (4 papers) and Mast cells and histamine (4 papers). Thomas Gentinetta collaborates with scholars based in Switzerland, United States and Australia. Thomas Gentinetta's co-authors include Oliver Hausmann, Werner J. Pichler, Chris H. Bridts, Didier G. Ebo, Monika Keller, Daniel Yerly, Michaela Fux, C. A. Dahinden, Peter Kopač and Rolf Gerber and has published in prestigious journals such as Blood, Free Radical Biology and Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

Thomas Gentinetta

13 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Gentinetta Switzerland	11	194	154	106	92	91	15	426
Roberta Parente Italy	10	128 0.7×	33 0.2×	183 1.7×	90 1.0×	85 0.9×	21	355
Donald MacGlashan United States	6	327 1.7×	35 0.2×	330 3.1×	200 2.2×	340 3.7×	8	677
E.N. Charlesworth United States	7	382 2.0×	60 0.4×	246 2.3×	152 1.7×	388 4.3×	8	650
Mamori Tani Japan	13	87 0.4×	20 0.1×	94 0.9×	79 0.9×	75 0.8×	30	462
R. Alam United States	11	178 0.9×	17 0.1×	360 3.4×	58 0.6×	208 2.3×	19	550
L. Pearce Collins United Kingdom	6	142 0.7×	37 0.2×	212 2.0×	199 2.2×	412 4.5×	7	610
Kenan Aydoğan Türkiye	11	17 0.1×	44 0.3×	74 0.7×	121 1.3×	21 0.2×	36	356
Nilgün Akdeniz Türkiye	8	29 0.1×	38 0.2×	164 1.5×	58 0.6×	24 0.3×	20	318
Shota Toyoshima Japan	11	59 0.3×	12 0.1×	146 1.4×	74 0.8×	62 0.7×	18	288
B. L. Park South Korea	11	37 0.2×	48 0.3×	50 0.5×	37 0.4×	150 1.6×	16	338

Countries citing papers authored by Thomas Gentinetta

Since Specialization

Citations

This map shows the geographic impact of Thomas Gentinetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gentinetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gentinetta more than expected).

Fields of papers citing papers by Thomas Gentinetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gentinetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gentinetta. The network helps show where Thomas Gentinetta may publish in the future.

Co-authorship network of co-authors of Thomas Gentinetta

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gentinetta. A scholar is included among the top collaborators of Thomas Gentinetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gentinetta. Thomas Gentinetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rahimi, Siavash, et al.. (2024). Standardized Production of Anti‐Desmoglein 3 Antibody AK23 for Translational Pemphigus Vulgaris Research. Current Protocols. 4(8). e1118–e1118.

Beckmann, Katrin, Thomas Gentinetta, Daniel Couto, et al.. (2024). Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep. Translational Stroke Research. 16(3). 728–732. 5 indexed citations

Vallelian, Florence, Raphael M. Buzzi, Ayla Yalamanoglu, et al.. (2022). Heme-stress activated NRF2 skews fate trajectories of bone marrow cells from dendritic cells towards red pulp-like macrophages in hemolytic anemia. Cell Death and Differentiation. 29(8). 1450–1465. 22 indexed citations

Buehler, Paul W., Scott K. Ferguson, Susan M. Majka, et al.. (2021). Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease. Free Radical Biology and Medicine. 175. 95–107. 13 indexed citations

Brinkman, Nathan, Thomas Gentinetta, M. Illa, et al.. (2021). Cell-free oxidized hemoglobin drives reactive oxygen species production and pro-inflammation in an immature primary rat mixed glial cell culture. Journal of Neuroinflammation. 18(1). 42–42. 16 indexed citations

Schaer, Christian A., Victor Jeger, Thomas Gentinetta, et al.. (2021). Haptoglobin treatment prevents cell-free hemoglobin exacerbated mortality in experimental rat sepsis. Intensive Care Medicine Experimental. 9(1). 22–22. 7 indexed citations

Buzzi, Raphael M., Catherine M. Owczarek, Kevin Akeret, et al.. (2021). Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics. Molecular Pharmaceutics. 18(8). 3158–3170. 10 indexed citations

Poillerat, Victoria, Thomas Gentinetta, Juliette Léon, et al.. (2020). Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation. Frontiers in Immunology. 11. 1684–1684. 24 indexed citations

Gentinetta, Thomas, et al.. (2020). Prevention of Heme-Induced Human Endothelial Cell Activation By Hemopexin in Vitro. Blood. 136(Supplement 1). 8–8.

10.

Kopač, Peter, Thomas Gentinetta, Rolf Gerber, et al.. (2011). Continuous apple consumption induces oral tolerance in birch‐pollen‐associated apple allergy. Allergy. 67(2). 280–285. 48 indexed citations

11.

Gentinetta, Thomas, Tatjana Pecaric-Petkovic, Franco H. Falcone, et al.. (2011). Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria. Journal of Allergy and Clinical Immunology. 128(6). 1227–1234.e5. 41 indexed citations

12.

Jandus, Peter, Oliver Hausmann, Gabrielle Haeberli, et al.. (2011). Unpredicted adverse reaction to omalizumab.. PubMed. 21(7). 563–6. 10 indexed citations

13.

Hausmann, Oliver, et al.. (2010). Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy. 66(1). 85–91. 68 indexed citations

14.

Pichler, Werner J., et al.. (2010). Drug Hypersensitivity Reactions: Pathomechanism and Clinical Symptoms. Medical Clinics of North America. 94(4). 645–664. 89 indexed citations

15.

Hausmann, Oliver, Thomas Gentinetta, Chris H. Bridts, & Didier G. Ebo. (2009). The Basophil Activation Test in Immediate-Type Drug Allergy. Immunology and Allergy Clinics of North America. 29(3). 555–566. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact